Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL27888295 | 1.00 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL27871725 | 1.00 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL4170715 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL7533455 | 1.00 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL28020955 | 0.96 | — | — | |
| Sulfuric Acid SCHEMBL11400477 | 0.96 | CA5A (0.46) | — | |
| Sulfuric Acid SCHEMBL27918664 | 0.96 | CA5A (0.46) | — | |
| Sulfuric Acid SCHEMBL5462395 | 0.96 | CA5A (0.46) | — | |
| Sulfuric Acid SCHEMBL7886319 | 0.96 | — | — | |
| Sulfuric Acid SCHEMBL2373322 | 0.93 | CA5A (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119462799-A | Fluorescein-labeled NRH derivative, synthesis and application thereof | 上海市第六人民医院 | 2025-02-18 | — | — | CN | claimed |
| CN-115840017-A | Method for analyzing SM3 isomer of mitrozole starting material | 南京恩泰医药科技有限公司 | 2023-03-24 | — | — | CN | claimed |
| CN-110514759-B | Method for detecting azide in candesartan cilexetil | 天地恒一制药股份有限公司 | 2022-05-20 | — | — | CN | claimed |
| CN-105510474-A | Method for measuring organic acid and soluble sugar in fruit or fruit wine at same time | INST OF AGRICULTURAL ENG TECH FUJIAN ACAD OF AGRICULTURAL SCIENCES | 2016-04-20 | — | — | CN | claimed |
| CN-104744300-A | Method for purifying acetonitrile for liquid chromatogram-mass spectrometer | XINGKE HIGH PURITY SOLVENTS SHANGHAI CO LTD | 2015-07-01 | — | — | CN | claimed |
| CN-102818872-A | High performance liquid chromatography for simultaneously detecting content of ten organic acids in fruit | INST AGRICULTURAL ENG TECHNOLOGY FUJIAN ACADEMY AGRICULTURAL SCIENCES | 2012-12-12 | — | — | CN | claimed |
| EP-4663639-A1 | SALT AND CRYSTAL OF MNK INHIBITOR COMPOUND AND PREPARATION METHOD THEREFOR | Novostar Pharmaceuticals, Ltd. (CN) | 2025-12-17 | — | — | EP | disclosed |
| CN-119462799-A | Fluorescein-labeled NRH derivative, synthesis and application thereof | 上海市第六人民医院 | 2025-02-18 | — | — | CN | disclosed |
| CN-119192165-A | Cyclic carbonate-sulfate compound, use thereof, nonaqueous electrolyte, and secondary battery | 深圳新宙邦科技股份有限公司 | 2024-12-27 | — | — | CN | disclosed |
| WO-2024164947-A1 | SALT AND CRYSTAL OF MNK INHIBITOR COMPOUND AND PREPARATION METHOD THEREFOR | 诺沃斯达药业(上海)有限公司 | 2024-08-15 | — | — | WO | disclosed |
| CN-118239883-A | Preparation method of lysine-specific demethylase 1 (LSD 1) inhibitor | 江苏联环药业股份有限公司 | 2024-06-25 | — | — | CN | disclosed |
| CN-114152692-B | Method for simultaneously measuring industrial sodium acetate and citric acid by ion chromatography | 成都市排水有限责任公司 | 2024-03-19 | — | — | CN | disclosed |
| CN-117327094-A | Compound or pharmaceutically acceptable salt thereof and crystal forms thereof | 上海艾力斯医药科技股份有限公司 | 2024-01-02 | — | — | CN | disclosed |
| US-20020091109-A1 | Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same | TEIJIN LIMITED | 2002-07-11 | — | — | US | disclosed |
| EP-1165497-A1 | METHOD OF PREPARING GRANULAR N-ALKYL-AMMONIUM ACETONITRILE SALTS | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-02 | — | — | EP | disclosed |
| EP-1123921-A1 | VITAMIN D 3? DERIVATIVES AND REMEDIES FOR INFLAMMATORY RESPIRATORY DISEASES CONTAINING THE SAME | TEIJIN LIMITED (JP) | 2001-08-16 | — | — | EP | disclosed |
| WO-2000058273-A1 | METHOD OF PREPARING GRANULAR N-ALKYL-AMMONIUM ACETONITRILE SALTS | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-05 | — | — | WO | disclosed |
| EP-0255098-B1 | Novel 8-(lower alkyl) bicyclo [4.2.0] octane derivatives with valuable therapeutic properties | SYNTEX (U.S.A.) INC. (US) | 1991-05-29 | — | — | EP | disclosed |
| US-4735966-A | ANTICOAGULANTS, VASODILATORS, HYPOTENSIVE AND ANTICHOLESTEROL AGENTS | SYNTEX (U.S.A.) INC. (US) | 1988-04-05 | — | — | US | disclosed |
| US-4678805-A | Novel 8-(lower alkyl)bicyclo[4.2.0]octane derivatives with valuable therapeutic properties | SYNTEX (U.S.A.) INC. (US) | 1987-07-07 | — | — | US | disclosed |